Foamix Pharmaceuticals Ltd. Realized Gains on Marketable Securities
Foamix Pharmaceuticals Ltd. reported Realized Gains on Marketable Securities of $1.08 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-12.
Discontinued › Income Statement › Other Income
us-gaap:MarketableSecuritiesRealizedGainLoss · last filed 2020-03-12
- Foamix Pharmaceuticals Ltd. marketable securities, realized gain (loss) for fiscal 2019 was $1.08M, a 57.41% increase from fiscal 2018.
- Foamix Pharmaceuticals Ltd. marketable securities, realized gain (loss) for fiscal 2018 was $688.00K, a 14.29% increase from fiscal 2017.
- Foamix Pharmaceuticals Ltd. marketable securities, realized gain (loss) for fiscal 2017 was $602.00K, a 50.12% increase from fiscal 2016.
- Foamix Pharmaceuticals Ltd. marketable securities, realized gain (loss) for fiscal 2016 was $401.00K.
| Period end | Marketable Securities, Realized Gain (Loss) 12 month |
|---|---|
| 2019-12-31 | $1.08M 10-K · filed 2020-03-12 |
| 2018-12-31 | $688.00K 10-K · filed 2020-03-12 |
| 2017-12-31 | $602.00K 10-K · filed 2020-03-12 |
| 2016-12-31 | $401.00K 10-K · filed 2019-02-28 |